When the Liver Flares: Inflammatory and Immunometabolic Mechanisms Driving the Transition from MASLD to MASH
Authors:
Open Access
- 16 June 2026
- journal article
- review article
- Published by Springer Nature in Inflammation
- Vol. 49 (1)
Abstract
The prevalence of metabolic dysfunction-associated steatotic liver disease (MASLD) is steadily increasing worldwide, primarily due to the ongoing obesity pandemic. Although MASLD may initially present as a relatively benign condition, it has the potential to progress to metabolic dysfunction-associated steatohepatitis (MASH), a more severe form that can lead to cirrhosis and hepatocellular carcinoma (HCC). A variety of factors contribute to the pathogenesis of MASLD, including gut dysbiosis, insulin resistance, dyslipidemia, lipotoxicity, and oxidative stress. Among these, recent evidence highlights chronic inflammation as a key driver of disease progression toward advanced stages. Global scientific efforts have begun to uncover the molecular mechanisms sustaining the inflammatory response in MASLD, although these pathways remain only partially understood. Furthermore, therapeutic options for MASLD and MASH are currently limited, with no approved pharmacological treatments available for the advanced stages of the disease. This review aims to provide a comprehensive overview of the current understanding of the cellular and molecular mechanisms involved in the inflammatory processes underpinning MASLD and MASH while also outlining the key challenges that lie ahead in the development of effective therapies.Keywords
Funding Information
- Università degli Studi del Piemonte Orientale Amedeo Avogrado
This publication has 292 references indexed in Scilit:
- The immunological interface: dendritic cells as key regulators in metabolic dysfunction‐associated steatotic liver diseaseFEBS Letters, 2024
- OPN‐Mediated Crosstalk Between Hepatocyte E4BP4 and Hepatic Stellate Cells Promotes MASH‐Associated Liver FibrosisAdvanced Science, 2024
- MASH as an emerging cause of hepatocellular carcinoma: current knowledge and future perspectivesMolecular Oncology, 2024
- The “Domino effect” in MASLD: The inflammatory cascade of steatohepatitisEuropean Journal of Immunology, 2024
- CX3CL1-CX3CR1 Interaction Prevents Carbon Tetrachloride-Induced Liver Inflammation and Fibrosis in MiceHepatology, 2010
- Accumulation of Natural Killer T Cells in Progressive Nonalcoholic Fatty Liver DiseaseHepatology, 2010
- Activation of the complement system in human nonalcoholic fatty liver disease†Hepatology, 2009
- A high-fat diet and regulatory T cells influence susceptibility to endotoxin-induced liver injuryHepatology, 2007
- Induction of murine liver damage by overexpression of CD40 ligand provides an experimental model to study fulminant hepatic failureHepatology, 2006
- Expression of class I and class II major histocompatibility complex antigens on human hepatocytesHepatology, 1988